Alberta Inc., a company following IFRS, has the following investments. Banff Limited bonds On January 1, 2021, Alberta Inc. purchased $500,000, 6% bonds of Banff Limited. The bonds pay interest annually every December 31, and would mature on December 31, 2027. The bonds were acquired to yield 6.5%. Alberta Inc. accounts for the investment under the FVOCI model. The market interest rate was 6.9% on December 31, 2021, but had dropped to 6.2% on December 31, 2022. Cochrane Corp common shares On April 1, 2022, Alberta Inc. acquired 20,000 shares of Cochrane Corps 100,000 outstanding shares at a price of $32 per share. The acquisition provided Alberta Inc. significant influence over Cochrane Corp. On this date, Cochrane Corps net book value was $2,400,000 and its assets and liabilities had fair values equal to their book values, except for an unrecorded patent having a fair value of $200,000 and a remaining useful life estimated to be 4 years. On July 31, 2022, Cochrane Corp declared and paid a dividend of $1 per share. Cochrane Corps net income for 2022 was $1,200,000, earned evenly during the year. On December 31, 2022, the shares of Cochrane Corp were trading on the Stock Exchange at $37 per share.

Required: Determine the amounts that Alberta Inc. would report in relation to each of its investments on its statement of comprehensive income for the year ended December 31, 2022 and its statement of financial position at that date. Show your work clearly for possible partial credit.